Colombia faces treaty dispute over cancer drug

Swiss pharmaceuticals group Novartis has threatened Colombia with an investment treaty claim over plans to impose price controls on a patented treatment for leukaemia, it has emerged.


Get unlimited access to all Global Arbitration Review content